Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

NCT00717236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1648

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Certolizumab pegol (CZP)
OTHER: Placebo

Sponsor

UCB Pharma